Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

New review highlights advances in diabetes research and treatment

A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.

25 Jul 2024

Texas Heart Institute and BiVACOR achieve milestone with total artificial heart implantation

The Texas Heart Institute (THI) and BiVACOR, a clinical-stage medical device company, announced today the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS) on July 9, 2024.

25 Jul 2024

Tiny titin mutation linked to developmental heart defects and adult atrial fibrillation

Millions of adults have atrial fibrillation -; an irregular beating of the upper chambers of the heart that yields increased risk of heart failure, stroke and death.

25 Jul 2024

High-risk NSAID prescriptions cost NHS £31 million

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm from them is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, finds a study published by The BMJ today.

24 Jul 2024

Community pharmacists help close gaps in stroke prevention for Afib patients

Atrial fibrillation (Afib) is the most common heart rhythm disorder encountered in clinical practice according to Dr. Roopinder Sandhu, MD, MPH, and the leading cause of stroke in older individuals.

24 Jul 2024

Boosting ketone levels enhances heart function in mice with HFpEF, study shows

Increasing ketone supply to the heart in mice with heart failure with preserved ejection fraction (HFpEF) allowed their hearts to utilize more ketones and produce more energy, according to preliminary research presented today at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2024.

24 Jul 2024

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

23 Jul 2024

New study sheds light on irregular heartbeat risk

Two new, basic animal research studies shed light on alcohol consumption and the heart. The first study may help explain why binge drinking sometimes causes an irregular heartbeat and a possible way to prevent it. The second study investigated why alcohol may have a negative impact on heart function in women taking estrogen replacement therapy.

23 Jul 2024

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications.

22 Jul 2024

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

Scimitar syndrome, a rare congenital heart disease, involves an anomalous pulmonary venous return where the right pulmonary veins return to the inferior vena cava instead of the left atrium.

18 Jul 2024

New four-year initiative targets cardiovascular-kidney-metabolic syndrome

About 1 in 3 U.S. adults have at least three risk factors for cardiovascular-kidney-metabolic (CKM) syndrome, a health disorder related to the strong connections among cardiovascular disease, kidney disease and metabolic disease (such as Type 2 diabetes and obesity).

18 Jul 2024

Tufts researchers uncover immune cell link to doxorubicin-induced heart damage

There's still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects.

17 Jul 2024

American Heart Association recognizes 3147 organizations for commitment to improving cardiovascular care

Someone in the United States dies of cardiovascular disease (CVD) every 34 seconds, on average. Reducing deaths from CVD requires a coordinated approach to care and a commitment to following science-based treatment guidelines.

17 Jul 2024

Heart of the Matter: Early Diagnosis and Intervention in Heart Failure with Prof. Martin Cowie & Dr. Lisa Anderson

The future of heart failure treatment with AstraZeneca's Prof. Martin Cowie and Heart Failure Specialist and Consultant Cardiologist at St George’s Hospital Dr. Lisa Anderson.

17 Jul 2024

Study analyzes lack of palliative care referrals for nursing home residents

Palliative care, specialized medical care focusing on providing relief from the symptoms -- including pain -- and the stress of serious illness, is underutilized in nursing homes, despite the large number of nursing home residents living with a serious illness such as cancer, dementia, Parkinson's disease, heart failure or chronic obstructive pulmonary disease.

16 Jul 2024

Consumer wearable devices provide clinical information similar to hospital assessment of heart disease

Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments for atrial fibrillation and heart failure.

15 Jul 2024

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

15 Jul 2024

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

12 Jul 2024

Groundbreaking method developed for analyzing heart MRI scans with AI

Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of artificial intelligence, which could save valuable NHS time and resources, as well as improve care for patients.

11 Jul 2024

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

10 Jul 2024

Heart Failure News and Research

Further Reading

New review highlights advances in diabetes research and treatment

Texas Heart Institute and BiVACOR achieve milestone with total artificial heart implantation

Tiny titin mutation linked to developmental heart defects and adult atrial fibrillation

High-risk NSAID prescriptions cost NHS £31 million

Community pharmacists help close gaps in stroke prevention for Afib patients

Boosting ketone levels enhances heart function in mice with HFpEF, study shows

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

New study sheds light on irregular heartbeat risk

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

New four-year initiative targets cardiovascular-kidney-metabolic syndrome

Tufts researchers uncover immune cell link to doxorubicin-induced heart damage

American Heart Association recognizes 3147 organizations for commitment to improving cardiovascular care

Heart of the Matter: Early Diagnosis and Intervention in Heart Failure with Prof. Martin Cowie & Dr. Lisa Anderson

Study analyzes lack of palliative care referrals for nursing home residents

Consumer wearable devices provide clinical information similar to hospital assessment of heart disease

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

Study reveals potential cognitive benefits of antidiabetic drugs

Groundbreaking method developed for analyzing heart MRI scans with AI

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News